Sinopharm Group Co. Ltd.

OTCPK:SHTD.F Stock Report

Market Cap: US$6.9b

Sinopharm Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:SHTD.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Jul 26SellUS$2,408,687JPMorgan Chase & Co.Company1,115,168US$2.16
16 Jul 26SellUS$3,462,845BlackRock, Inc.Company1,564,000US$2.21
03 Jul 26BuyUS$6,840,138JPMorgan Chase & Co.Company3,214,654US$2.13
30 Jun 26SellUS$1,040,509JPMorgan Chase & Co.Company509,814US$2.04
26 Jun 26BuyUS$7,407,079China CITIC Financial Asset Management Co., Ltd.Company3,662,400US$2.02
16 Jun 26SellUS$4,294,710FMR LLCCompany2,000,000US$2.15
01 Jun 26SellUS$3,836,628CITIC Securities Company LimitedCompany1,775,200US$2.16
22 May 26SellUS$13,426,170FMR LLCCompany5,947,847US$2.26
12 May 26SellUS$4,696,362FMR LLCCompany1,997,600US$2.35
28 Apr 26SellUS$1,845,569FMR LLCCompany749,200US$2.46
31 Mar 26BuyUS$23,574,614Jpmorgan Asset Management (China) Company LimitedCompany9,151,938US$2.58
26 Mar 26SellUS$4,327,730JPMorgan Chase & Co.Company1,682,928US$2.57
25 Mar 26BuyUS$4,042,496JPMorgan Chase & Co.Company1,584,619US$2.55
24 Mar 26BuyUS$5,245,726Lazard Asset Management LLCCompany2,096,025US$2.50
23 Mar 26SellUS$9,777,745JPMorgan Chase & Co.Company3,763,559US$2.60
09 Mar 26BuyUS$1,202,076JPMorgan Chase & Co.Company459,664US$2.62
04 Mar 26BuyUS$9,597,814Lazard Asset Management LLCCompany3,637,200US$2.64
03 Mar 26BuyUS$46,474,819Lazard Asset Management LLCCompany17,353,148US$2.68
20 Feb 26SellUS$1,167,339JPMorgan Chase & Co.Company433,572US$2.69
16 Feb 26BuyUS$899,076JPMorgan Chase & Co.Company328,153US$2.74
05 Feb 26SellUS$12,727,494JPMorgan Chase & Co.Company4,731,697US$2.69
02 Feb 26BuyUS$3,082,511Lazard Asset Management LLCCompany1,163,040US$2.65
30 Jan 26BuyUS$2,519,208JPMorgan Chase & Co.Company943,377US$2.67
24 Nov 25BuyUS$403,401JPMorgan Chase & Co.Company154,800US$2.61
24 Nov 25BuyUS$31,271JPMorgan Chase & Co.Company12,000US$2.61
24 Nov 25SellUS$8,112,319JPMorgan Chase & Co.Company3,113,001US$2.61
21 Nov 25BuyUS$5,290,108JPMorgan Chase & Co.Company2,047,601US$2.58
12 Nov 25BuyUS$3,016,717BlackRock, Inc.Company1,101,600US$2.74
02 Oct 25BuyUS$562,400Lazard Asset Management LLCCompany235,200US$2.39
29 Sep 25BuyUS$2,349JPMorgan Chase & Co.Company1,000US$2.35
29 Sep 25SellUS$8,419,073JPMorgan Chase & Co.Company3,583,972US$2.35
26 Sep 25BuyUS$9,152,937JPMorgan Chase & Co.Company3,914,558US$2.34
24 Sep 25SellUS$1,298,159Lazard Asset Management LLCCompany546,400US$2.38
23 Sep 25SellUS$3,127,040FMR LLCCompany1,318,800US$2.37
11 Sep 25SellUS$3,204,090JPMorgan Chase & Co.Company1,317,837US$2.43
09 Sep 25BuyUS$1,520,827Lazard Asset Management LLCCompany636,800US$2.39
01 Sep 25BuyUS$159,952JPMorgan Chase & Co.Company66,405US$2.41
01 Sep 25SellUS$2,704,534JP Morgan Asset ManagementCompany1,122,800US$2.41
29 Aug 25BuyUS$1,486,058JPMorgan Chase & Co.Company618,584US$2.40
29 Aug 25BuyUS$8,437,067Jpmorgan Asset Management (China) Company LimitedCompany3,512,000US$2.40
29 Aug 25SellUS$4,074,392JP Morgan Asset ManagementCompany1,696,000US$2.40
28 Aug 25SellUS$2,987,499JPMorgan Chase & Co.Company1,249,509US$2.39
19 Aug 25BuyUS$4,822,916JPMorgan Chase & Co.Company1,913,343US$2.52
13 Aug 25BuyUS$145,154BlackRock, Inc.Company59,164US$2.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SHTD.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies67,205,2002.15%
General Public388,861,56212.5%
Institutions885,743,97828.4%
Private Companies1,778,845,45157%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 85.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
57%
China National Pharmaceutical Group Corporation
1,778,845,451US$3.9b0%no data
5.65%
Lazard Asset Management LLC
176,179,206US$390.4m31.2%0.33%
4.69%
CITIC Securities Company Limited
146,222,820US$324.0m-1.53%3.43%
4.26%
BlackRock, Inc.
132,942,358US$294.6m34.4%no data
3%
FMR LLC
93,560,154US$207.3m-36.3%0.01%
2.15%
China CITIC Financial Asset Management Co., Ltd.
67,205,200US$148.9m0%0.64%
1.5%
Vanguard Capital Management, LLC
46,801,286US$103.7m-0.12%no data
0.93%
Dimensional Fund Advisors LP
28,932,534US$64.1m1.15%0.01%
0.69%
Wasatch Advisors LP
21,390,800US$47.4m0%0.17%
0.59%
Norges Bank Investment Management
18,309,928US$40.6m0%no data
0.56%
Letko, Brosseau & Associates Inc.
17,395,000US$38.5m0%0.42%
0.55%
Jpmorgan Asset Management (China) Company Limited
17,250,000US$38.2m0%3.48%
0.51%
Hang Seng Investment Management Limited
15,962,576US$35.4m-0.28%0.11%
0.41%
Geode Capital Management, LLC
12,938,341US$28.7m3.09%no data
0.39%
Invesco Great Wall Fund Management Co. Ltd
12,023,200US$26.6m0%0.08%
0.37%
Vanguard Fiduciary Trust Company
11,590,615US$25.7m0.71%no data
0.35%
Charles Schwab Investment Management, Inc.
10,841,760US$24.0m-19.1%no data
0.29%
American Century Investment Management Inc
8,966,800US$19.9m7.14%0.01%
0.23%
Bosera Asset Management Co., Ltd.
7,035,600US$15.6m0%0.06%
0.21%
Fidelity International Ltd
6,628,278US$14.7m0.74%no data
0.2%
China Asset Management Co. Ltd.
6,274,403US$13.9m2.9%0.01%
0.19%
Pacific Investment Management Company LLC
5,875,600US$13.0m0.7%0.03%
0.14%
UBS Asset Management AG
4,317,729US$9.6m-0.27%no data
0.14%
State Street Global Advisors, Inc.
4,297,600US$9.5m-0.85%no data
0.13%
China Southern Asset Management Co., Ltd.
3,952,800US$8.8m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/02 23:21
End of Day Share Price 2026/06/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sinopharm Group Co. Ltd. is covered by 33 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason MannBarclays
Bo LiBofA Global Research
Xiwan JinCCB International Securities Limited